What are the clinical features and management of plaque psoriasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Plaque psoriasis should be managed with a stepped approach, starting with topical therapies for mild disease, progressing to phototherapy for moderate disease, and utilizing systemic treatments, including biologics like etanercept, for severe cases, as this approach has been shown to effectively reduce morbidity and improve quality of life 1. The clinical features of plaque psoriasis include well-demarcated, erythematous plaques with silvery scales typically found on extensor surfaces, scalp, and trunk.

  • Key characteristics of plaque psoriasis include:
    • Erythematous plaques with silvery scales
    • Typically found on extensor surfaces, scalp, and trunk
    • Can be associated with psoriatic arthritis and other comorbidities Management of plaque psoriasis depends on the severity of the disease, with mild cases often treated with topical therapies such as:
  • Corticosteroids (e.g., betamethasone dipropionate 0.05% applied twice daily)
  • Vitamin D analogs (e.g., calcipotriene 0.005% ointment)
  • Calcineurin inhibitors For moderate-to-severe disease, phototherapy with narrowband UVB three times weekly for 2-3 months is effective, and systemic treatments such as methotrexate, cyclosporine, and acitretin may be used.
  • Biologics, including TNF inhibitors like etanercept, have been shown to be highly effective in treating severe plaque psoriasis, with etanercept demonstrating clinical effectiveness in achieving clearance or near clearance of disease in 38% and 54% of patients after 12 weeks of treatment at 25 mg and 50 mg twice weekly, respectively 1. Treatment with etanercept should be initiated at 25 mg subcutaneously, twice weekly, with the option to increase to 50 mg twice weekly based on individual patient response and clinical need 1. Regular monitoring for treatment efficacy and side effects is essential, with treatment adjustments made as needed to optimize outcomes and minimize morbidity and mortality.

From the Research

Clinical Features of Plaque Psoriasis

  • Plaque psoriasis is a chronic inflammatory skin disease characterized by erythematous lesions covered with silvery scales 2
  • It is the most common form of psoriasis, affecting approximately 1-3% of the Caucasian population 3
  • Clinical features include redness, thickness, and scaling of the skin 4, 5

Management of Plaque Psoriasis

  • First-line management of chronic plaque psoriasis is with topical treatments, including vitamin D analogues, topical corticosteroids, tar-based preparations, dithranol, salicylic acid, and topical retinoids 5
  • Topical corticosteroids are the primary treatment strategy for most mild to moderate cases of psoriasis 2
  • Combination therapy with calcipotriene and betamethasone dipropionate is an effective treatment for plaque psoriasis, offering better efficacy, safety, and ease of use compared to separate product monotherapies 6, 3
  • Vitamin D analogues and potent corticosteroids have been shown to be effective in treating plaque psoriasis, with combined treatment with vitamin D and corticosteroid performing significantly better than vitamin D alone or corticosteroid alone 4, 5

Treatment Options

  • Topical treatments available for plaque psoriasis include:
    • Vitamin D analogues (e.g. calcipotriol) 6, 3, 4, 5
    • Topical corticosteroids (e.g. betamethasone dipropionate) 6, 3, 4, 2, 5
    • Tar-based preparations 5
    • Dithranol 5
    • Salicylic acid 5
    • Topical retinoids 5
  • Combination therapy with calcipotriol and betamethasone dipropionate is available in various formulations, including ointment, gel, suspension, foam, and cream 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Topical treatments for chronic plaque psoriasis: an abridged Cochrane systematic review.

Journal of the American Academy of Dermatology, 2013

Research

Topical treatments for chronic plaque psoriasis.

The Cochrane database of systematic reviews, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.